Business Description
Yifeng Pharmacy Chain Co Ltd
ISIN : CNE100001TS5
Share Class Description:
SHSE:603939: Class ACompare
Compare
Traded in other countries / regions
603939.China IPO Date
2015-02-17Description
Yifeng Pharmacy Chain Co Ltd is mainly engaged in the chain retail business of medicines, health products, medical devices and health-related daily convenience products.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.45 | |||||
| Equity-to-Asset | 0.38 | |||||
| Debt-to-Equity | 0.54 | |||||
| Debt-to-EBITDA | 2.36 | |||||
| Interest Coverage | 11.52 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 2.62 | |||||
| Beneish M-Score | -3.12 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 18 | |||||
| 3-Year EBITDA Growth Rate | 19.6 | |||||
| 3-Year EPS without NRI Growth Rate | 20.2 | |||||
| 3-Year FCF Growth Rate | 28.6 | |||||
| 3-Year Book Growth Rate | 20.5 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 18.2 | |||||
| Future 3-5Y Total Revenue Growth Rate | 12.87 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 45.33 | |||||
| 9-Day RSI | 43.06 | |||||
| 14-Day RSI | 46.38 | |||||
| 6-1 Month Momentum % | -36.19 | |||||
| 12-1 Month Momentum % | -21.86 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.19 | |||||
| Quick Ratio | 0.88 | |||||
| Cash Ratio | 0.66 | |||||
| Days Inventory | 93.31 | |||||
| Days Sales Outstanding | 29.75 | |||||
| Days Payable | 198.82 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 3.2 | |||||
| Dividend Payout Ratio | 0.39 | |||||
| 3-Year Dividend Growth Rate | 50.3 | |||||
| Forward Dividend Yield % | 3.2 | |||||
| 5-Year Yield-on-Cost % | 10.41 | |||||
| 3-Year Average Share Buyback Ratio | -1.5 | |||||
| Shareholder Yield % | -2.33 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 38.89 | |||||
| Operating Margin % | 9.52 | |||||
| Net Margin % | 6.37 | |||||
| FCF Margin % | 17.92 | |||||
| ROE % | 15.22 | |||||
| ROA % | 6.05 | |||||
| ROIC % | 12.72 | |||||
| ROC (Joel Greenblatt) % | 40.66 | |||||
| ROCE % | 16.74 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 18.63 | |||||
| Forward PE Ratio | 14.98 | |||||
| PE Ratio without NRI | 18.24 | |||||
| Shiller PE Ratio | 37.17 | |||||
| Price-to-Owner-Earnings | 26.7 | |||||
| PEG Ratio | 0.43 | |||||
| PS Ratio | 1.19 | |||||
| PB Ratio | 2.77 | |||||
| Price-to-Tangible-Book | 5.71 | |||||
| Price-to-Free-Cash-Flow | 6.6 | |||||
| Price-to-Operating-Cash-Flow | 5.62 | |||||
| EV-to-EBIT | 11.03 | |||||
| EV-to-EBITDA | 11.03 | |||||
| EV-to-Revenue | 1.08 | |||||
| EV-to-FCF | 6.32 | |||||
| Price-to-Projected-FCF | 0.68 | |||||
| Price-to-DCF (Earnings Based) | 0.58 | |||||
| Price-to-DCF (FCF Based) | 0.21 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.81 | |||||
| Price-to-Graham-Number | 2.15 | |||||
| Earnings Yield (Greenblatt) % | 9.07 | |||||
| FCF Yield % | 15.09 | |||||
| Forward Rate of Return (Yacktman) % | 28.9 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Yifeng Pharmacy Chain Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 23,919.078 | ||
| EPS (TTM) (Â¥) | 1.257 | ||
| Beta | 1.48 | ||
| Volatility % | 49.46 | ||
| 14-Day RSI | 46.38 | ||
| 14-Day ATR (Â¥) | 0.987531 | ||
| 20-Day SMA (Â¥) | 24.5555 | ||
| 12-1 Month Momentum % | -21.86 | ||
| 52-Week Range (Â¥) | 17.56 - 39.066666 | ||
| Shares Outstanding (Mil) | 1,212.43 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Yifeng Pharmacy Chain Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Yifeng Pharmacy Chain Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Yifeng Pharmacy Chain Co Ltd Frequently Asked Questions
What is Yifeng Pharmacy Chain Co Ltd(SHSE:603939)'s stock price today?
The current price of SHSE:603939 is ¥23.42. The 52 week high of SHSE:603939 is ¥39.07 and 52 week low is ¥17.56.
When is next earnings date of Yifeng Pharmacy Chain Co Ltd(SHSE:603939)?
The next earnings date of Yifeng Pharmacy Chain Co Ltd(SHSE:603939) is .
Does Yifeng Pharmacy Chain Co Ltd(SHSE:603939) pay dividends? If so, how much?
The Dividend Yield %  of Yifeng Pharmacy Chain Co Ltd(SHSE:603939) is 3.2% (As of Today), Highest Dividend Payout Ratio of Yifeng Pharmacy Chain Co Ltd(SHSE:603939) was 0.43. The lowest was 0.15. And the median was 0.25. The  Forward Dividend Yield % of Yifeng Pharmacy Chain Co Ltd(SHSE:603939) is 3.2%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers